Prevalence of HIV and hepatitis B virus co-infection in sub-Saharan Africa and the potential impact and program feasibility of hepatitis B surface antigen screening in resource-limited settings

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Lara StabinskiTiffany E Hamm

Abstract

Screening people living with HIV for hepatitis B virus (HBV) co-infection is recommended in resource-rich settings to optimize HIV antiretroviral therapy (ART) and mitigate HBV-related liver disease. This review examines the need, feasibility, and impact of screening for HBV in resource-limited settings (RLS). We searched 6 databases to identify peer-reviewed publications between 2007 and 2013 addressing (1) HIV/HBV co-infection frequency in sub-Saharan Africa (SSA); (2) performance of hepatitis B surface antigen (HBsAg) rapid strip assays (RSAs) in RLS; (3) impact of HBV co-infection on morbidity, mortality, or liver disease progression; and/or (4) impact of HBV-suppressive antiretroviral medications as part of ART on at least one of 5 outcomes (mortality, morbidity, HIV transmission, retention in HIV care, or quality of life). We rated the quality of individual articles and summarized the body of evidence and expected impact of each intervention per outcome addressed. Of 3940 identified studies, 85 were included in the review: 55 addressed HIV/HBV co-infection frequency; 6 described HBsAg RSA performance; and 24 addressed the impact of HIV/HBV co-infection and ART. HIV/HBV frequency in sub-Saharan Africa varied from 0% to >28...Continue Reading

References

Nov 15, 1992·Annals of Internal Medicine·B F ScharschmidtM M Thaler
Jul 1, 1997·Journal of Hepatology·J OckengaR E Schmidt
Aug 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M BessesenK E Sherman
Dec 21, 2002·Lancet·Chloe L ThioUNKNOWN Multicenter AIDS Cohort Study
May 27, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·M Jeffrey MphahleleJohannes M Ngobeni
Jun 24, 2005·Journal of Hepatology·Dominique Salmon-CeronUNKNOWN Mortality 2000 study group
Aug 16, 2006·Archives of Internal Medicine·Rainer WeberJens D Lundgren
May 25, 2007·The Lancet Infectious Diseases·Christopher J Hoffmann, Chloe L Thio
Oct 16, 2007·Journal of Medical Virology·Maria F PirilloMarina Giuliano
Mar 18, 2008·International Braz J Urol : Official Journal of the Brazilian Society of Urology·Elisabetta CostantiniMassimo Porena
Jun 6, 2008·AIDS·Reena Shah HaraniaJustin Stebbing
Oct 22, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher J HoffmannChloe L Thio
Feb 24, 2009·Journal of Hepatology·Dominique Salmon-CeronUNKNOWN ANRS EN19 Mortalité Study Group and Mortavic
Jun 25, 2009·AIDS·Christopher J HoffmannChloe L Thio
Sep 18, 2009·Journal of Infection in Developing Countries·Olanisun Olufemi AdewoleGreg Efosa Erhabor
Nov 26, 2009·Transactions of the Royal Society of Tropical Medicine and Hygiene·J DaviesM B J Beadsworth
Dec 1, 2009·Pakistan Journal of Biological Sciences : PJBS·D OuermiG B Kabre
May 18, 2010·The Journal of Infection·E MooreJ J van Oosterhout
Jul 16, 2010·Journal of Clinical Microbiology·Anna Maria GerettiRichard Odame Phillips
Aug 31, 2010·Gastroenterology·Theodora E M S de Vries-SluijsMarchina E van der Ende
Sep 14, 2010·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Denise IlboudoSalvatore Musumeci
Sep 17, 2010·Virology Journal·Modou JobartehMaimuna Mendy
Nov 3, 2010·Antiviral Therapy·Thérèse N'Dri-YomanChristine Danel
Feb 19, 2011·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·José M RamosFélix Gutiérrez
Aug 5, 2011·The American Journal of Tropical Medicine and Hygiene·Premal PatelGabriel Anabwani
Sep 3, 2011·Journal of Global Infectious Diseases·Kenneth C KapembwaBenjamin H Chi
Dec 8, 2011·The Journal of Infectious Diseases·Helen M ChunUNKNOWN Infectious Disease Clinical Research Program HIV Working Group
Feb 7, 2012·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Cindy FirnhaberAnna Kramvis

❮ Previous
Next ❯

Citations

Jul 28, 2016·BMC Infectious Diseases·Tegwinde Rebeca CompaoreJacques Simpore
Apr 1, 2016·PloS One·Gilles WandelerUNKNOWN IeDEA-Southern Africa
Mar 21, 2017·Journal of Immunoassay & Immunochemistry·B A OlusolaG N Odaibo
Mar 18, 2017·Current Opinion in HIV and AIDS·Philippa J EasterbrookRosanna Peeling
Oct 12, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gérard-Menan KouaméUNKNOWN French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 12136 Temprano and ANRS 12240 VarBVA Study Groups
Mar 24, 2018·International Journal of Cancer. Journal International Du Cancer·Antoine JaquetFrançois Dabis
Jun 16, 2017·Journal of Medical Virology·Oluwapelumi O AdeyemiOlajide O Agbede
Jul 28, 2017·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Amy E GreerAlexandra Valsamakis
Nov 18, 2015·World Journal of Gastroenterology : WJG·Rosa ZampinoNicola Coppola
Oct 29, 2018·AIDS Research and Therapy·P Cornejo-JuárezP Volkow-Fernández
May 4, 2017·BMC Infectious Diseases·Justine UmutesiSabin Nsanzimana
Nov 17, 2017·BMC Infectious Diseases·Patrick A CoffieUNKNOWN IeDEA collaboration
May 25, 2021·Journal of Immunoassay & Immunochemistry·Oluwadamilola Gideon OsasonaOluwatosin Oluwagbenga Oguntoye

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.